The prevalence of undiagnosed postoperative lower limb lymphedema among gynecological oncology patients.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
05 2022
Historique:
received: 24 09 2021
revised: 13 12 2021
accepted: 25 12 2021
pubmed: 5 1 2022
medline: 12 5 2022
entrez: 4 1 2022
Statut: ppublish

Résumé

Lower limb lymphedema (LLL) is a common postoperative complication among gynecological oncology patients following lymph node resection. In the absence of a screening strategy, LLL is frequently diagnosed only through patient's self-reported symptoms. This study investigated the prevalence of undiagnosed postoperative LLL among gynecological oncology patients and identified the associated risk factors. This was a cross-sectional postal questionnaire survey at a tertiary gynecological oncology center. Women with gynecological malignancies who underwent lymph node (inguinal/pelvic/para-aortic) resection between 2010 and 2017 were eligible. The Gynecological Cancer Lymphedema Questionnaire (GCLQ) was used and those with a score of ≥4 were referred to a lymphedema specialist for clinical confirmation. Among 376 eligible women, postoperative LLL was already diagnosed in 45/376 (12%) women. In the remaining women, 117/331 (35.3%) completed the GCLQ, of which 67/117 (57.3%) scored ≥4. Fifty-five women (55/67, 82.1%) were assessed by a lymphedema specialist and eight cases of postoperative LLL were confirmed. In the 12/67 who declined a clinical assessment, they reported no evidence of LLL. The prevalence of undiagnosed postoperative LLL in our study was 8/117 (6.8%, 95% C.I. 2.3-11.4). On univariate analysis, older women were more likely to have undiagnosed postoperative LLL. Undiagnosed postoperative LLL is not uncommon among gynecological oncology patients, especially in older patients. No vulvar cancer patient had undiagnosed LLL. Increased awareness and improved strategies for lymphedema screening are required after lymph node surgery in gynecological oncology.

Identifiants

pubmed: 34980543
pii: S0748-7983(21)01436-0
doi: 10.1016/j.ejso.2021.12.464
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1167-1172

Informations de copyright

Copyright © 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Michael Wong (M)

Department of Gynecological Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom. Electronic address: michael.wong3@nhs.net.

Patricia Kay Eaton (PK)

Lymphedema Service, Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Carla Zanichelli (C)

Lymphedema Service, Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Christina Moore (C)

Lymphedema Service, Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Catherine Hegarty (C)

Lymphedema Service, Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Nicola MacDonald (N)

Department of Gynecological Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH